Biotech2k
Biotech Investor, AI-Driven Drug Discovery
T1 Energy's problems are now self-inflicted: a costly buyout is burning cash the company desperately needs, and the market is done handing out free capital. Management assumed it could keep raising money and spend endlessly. The small speculative bet has gone wrong; no more buying for now, and if the thesis proves wrong it gets replaced with something better. x.com x.com x.com
T1 Energy's growth could accelerate once its second photovoltaic cell facility is running. It is a speculative play on rising energy demand and the need for cleaner energy for data centers and electric vehicles, already growing over 40% with one plant manufacturing. A market cap below $2 billion against more than $1.3 billion in expected 2027 sales looks like a really good value, though this is a very early-stage story with a lot of risk. x.com
T1 Energy is not worth buying: John Tinsman warns that unprofitable businesses such as T1 face dilution risk, high stock-based compensation, unlikely future promises and difficulty valuing them in a panic. x.com x.com
T1 Energy remains unattractive because, as an unprofitable business, it faces high dilution risk, substantial stock-based compensation, reliance on unlikely future promises and valuation that becomes difficult in a panic. x.com
T1 Energy's $135M purchase of formerly licensed TOPCon IP could save $25M-$40M in annual fees and improve future margins. A waiver to import up to 1.725 GW of cells could bridge Dallas production until G2 Austin starts in Q1 2027. It could be one of the energy sector's most interesting turnarounds, but is not proven: $120M in convertible debt has been raised, more funding is needed, and further debt or equity could limit existing shareholders' upside. x.com
T1 Energy looks unattractive because its management can't be trusted. Against a claim that it is a safe risk that will boom like SanDisk, it more likely won't. x.com x.com
T1 Energy is a high-capex, low-margin business now borrowing its way to zero, shown by its $120 million private offering of 4.75% convertible senior notes due 2031. Earlier red flags were massively overleveraged debt, a shady founder, a lawsuit from one of Europe's largest utilities, FEOC credit eligibility it claims but has not officially secured, and a questionable plan to repay Chinese debt to qualify for US subsidies. x.com x.com
T1 Energy's G2_Austin buildout is a sign of life, but financing its costly first phase remains a major risk. The company estimates more than $500 million in total capex for its 2.1 GW Phase 1. Backup financing is likely to bring significant dilution; without funding, bankruptcy and an asset sale or dilution toward zero and a reverse split are likely. The price looks very interesting and the setup asymmetric, though downside remains significant. x.com x.com
T1 Energy is likely to struggle until financing terms are announced, though its long-term potential still justifies holding. x.com
T1 Energy's funding path for its G2 Austin solar-cell project is still unresolved, so it is one to watch from the sidelines. Its new $50 million of 4.75% convertible notes is incremental financing to bridge to a bigger package under Plan A or Plan B. Funding looks achievable and Plan A is most attractive; Plan B could depend on monetizing its Nordic assets. Phase 1 should be highly profitable once built, especially with Section 232 tariffs in place. x.com x.com x.com
T1 Energy is building toward US solar cell production with its G2 plant in Texas. The $425M first phase is underway, the full $850M project should create about 1,800 jobs, and G2 should be producing solar cells by year-end. Tesla scaling its own solar production with SpaceX is not a competitive worry: it reflects a broader trend toward localized manufacturing and confirms the solar market will be big enough for other players. It is a long-term hold with its own risks. x.com x.com x.com
T1 Energy is a capital-structure story before a solar story. Its Q2 adjusted EBITDA turned positive only because a one-time tariff refund was moved into a metric guided to exclude it. Modules went only to related parties, giving no independent read on price. SG&A now exceeds gross profit, cash burn soared, inventory ballooned, and the Austin cell fab slipped a quarter as its budget rose. The ramp and policy tailwind are real, but a funded Phase 1 and a third-party customer come first. x.com
